HeitJA. Epidemiology of venous thromboembolism. Nat Rev Cardiol, 2015; 12:464–474.
2.
KleinSK, SlimEJ, de KruifMD, et al.Is chronic HIV infection associated with venous thrombotic disease? A systematic review. Neth J Med, 2005; 63:129–136.
3.
Majluf-CruzA, Silva-EstradaM, Sanchez-BarbozaR, et al.Venous thrombosis among patients with AIDS. Clin Appl Thromb Hemost, 2004; 10:19–25.
4.
MattaF, YaekoubAY, SteinPD. Human immunodeficiency virus infection and risk of venous thromboembolism. Am J Med Sci, 2008; 336:402–406.
5.
O'BrienMP, ZafarMU, RodriguezJC, et al.Targeting thrombogenicity and inflammation in chronic HIV infection. Sci Adv, 2019; 5:eaav5463.
6.
KiserKL, BadowskiME. Risk factors for venous thromboembolism in patients with human immunodeficiency virus infection. Pharmacotherapy, 2010; 30:1292–1302.
RasmussenLD, DybdalM, GerstoftJ, et al.HIV and risk of venous thromboembolism: A Danish nationwide population-based cohort study. HIV Med, 2011; 12:202–210.
9.
FultzSL, McGinnisKA, SkandersonM, RagniMV, JusticeAC. Association of venous thromboembolism with human immunodeficiency virus and mortality in veterans. Am J Med, 2004; 116:420–423.
10.
MalekJ, RogersR, KuferaJ, HirshonJM. Venous thromboembolic disease in the HIV-infected patient. Am J Emerg Med, 2011; 29:278–282.
11.
HowlingSJ, ShawPJ, MillerRF. Acute pulmonary embolism in patients with HIV disease. Sex Transm Infect, 1999; 75:25–29.
12.
CopurAS, SmithPR, GomezV, BergmanM, HomelP. HIV infection is a risk factor for venous thromboembolism. AIDS Patient Care STDS, 2002; 16:205–209.
